Results 191 to 200 of about 1,359,664 (362)

Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide. [PDF]

, 1987
Robert C. Fuhlbrigge, David Chaplin, Jeanne-Marie Kíely, Emil R. Unanue   +3 more
openalex   +1 more source

Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases

Advanced Healthcare Materials, EarlyView.
This review highlights recent advances in nanoparticle‐based strategies to modulate neutrophil activity in inflammatory diseases. By targeting inflammatory neutrophils, NET formation, and neutrophil apoptosis or recruitment, these approaches aim to improve therapeutic precision.
Min Ji Byun, Elizabeth S. Nakasone, Ha Eun Shin, Hyojin Lee, Jong‐Chan Park, Wonhwa Lee, Wooram Park, Chun Gwon Park, Juwon Park, Se‐Na Kim   +9 more
wiley   +1 more source

Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell. [PDF]

, 1987
Thomas S. Kupper, Mark C. Horowitz, F Lee, R J Robb, Patrick M. Flood   +4 more
openalex   +1 more source

Coordinated Development of Immune Cell Populations in Vascularized Skin Organoids from Human Induced Pluripotent Stem Cells

Advanced Healthcare Materials, EarlyView.
Vascularized skin organoids are developed from human induced pluripotent stem cells and contain macrophages, Langerhans cells, and neutrophils. Vascularized skin organoids offer a transformative platform to model skin biology and enable mechanistic investigations of inflammatory and hematologic skin disorders.
Mitchell Mostina, Jane Sun, Seen Ling Sim, Imaan A. Ahmed, Fernando Souza‐Fonesca‐Guimaraes, Ernst J. Wolvetang, Jason Brown, Snehlata Kumari, Kiarash Khosrotehrani, Abbas Shafiee   +9 more
wiley   +1 more source

Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. [PDF]

, 1985
J Vilček, D Henriksen-DeStefano, David S. Siegel, Amy D. Klion, R J Robb, Junming Le   +5 more
openalex   +1 more source

Mesoporous Bioactive Glasses: A Powerful Tool in Tissue Engineering and Drug Delivery

Advanced Healthcare Materials, EarlyView.
This work is a comprehensive revision of bioactive glasses (BGs), pioneered by Prof. L.L. Hench, which are key in bone repair and regenerative medicine. Sol–gel methods and mesoporous designs enhanced their bioactivity, ions, and drug delivery. BGs now support gene therapy and 3D‐printed scaffolds, enabling personalized, multifunctional treatments in ...
Natividad Gómez‐Cerezo, Daniel Lozano, Antonio J. Salinas, María Vallet‐Regí   +3 more
wiley   +1 more source

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth. [PDF]

, 1985
Martin A. Cheever, John A. Thompson, D E Kern, Philip D. Greenberg   +3 more
openalex   +1 more source

Guides for Developing Hundreds of Novel Chiral MXenes and MBenes Nanosheets/Quantum Dots for Next‐Generation Chiral Engineered Biomaterials Applications

Advanced Healthcare Materials, EarlyView.
The emerging field of MXene/MBene materials has progressed rapidly, advancing diverse research fields, including biomedical engineering, biomedicine, agriculture, and the environment. This nanobiotechnology can tackle longstanding challenges in these areas.
Alireza Rafieerad, Ahmad Amiri
wiley   +1 more source

Predictive Biomarker for Cardiac Surgery-Associated Acute Kidney Injury: A Retrospective Analysis. [PDF]

Braz J Cardiovasc Surg
Zhang B, Zhang D, Wang S, Yu H.
europepmc   +1 more source

Presentation of antigen by B cells: functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation. [PDF]

, 1985
Michael A. Frohman, Carol Cowing
openalex   +1 more source